Related Experiment Videos
Metalloproteinases in canine experimental traumatic keratoconjunctivitis
1Department of Surgery, Faculty of Veterinary Science, University of Selçuk, Konya, Turkey.
Summary
Matrix metalloproteinases (MMPs), particularly MMP-9, were significantly elevated in the tears of dogs with keratoconjunctivitis. These findings suggest MMPs may indicate corneal deterioration in canine eye diseases.
Area of Science:
- Ophthalmology
- Veterinary Medicine
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are implicated in various ocular diseases.
- MMPs, including MMP-9 (gelatinase-B), may be present and active in tear fluid.
- Understanding MMP activity is crucial for diagnosing and managing canine eye conditions.
Purpose of the Study:
- To investigate the presence and activity of MMPs in the tears of dogs with keratoconjunctivitis.
- To determine if MMP-9 levels correlate with the severity of canine eye disease.
- To assess the potential of MMPs as biomarkers for corneal deterioration.
Main Methods:
- Tear samples were collected from dogs diagnosed with keratoconjunctivitis and healthy controls.
- Gelatine zymography was employed to measure overall MMP activity.
- Gelatine degradation ELISA was used to quantify active gelatinase levels, specifically MMP-9.
Main Results:
- Elevated monomer and dimer enzyme activity of MMP-9 was observed in tears from keratoconjunctivitis cases compared to normal tears (P < 0.001).
- Gelatinase bioactivities were significantly increased in tears associated with keratoconjunctivitis disease (P < 0.01).
- The presence of biologically active MMP forms indicates their direct involvement in the disease process.
Conclusions:
- Matrix metalloproteinases, particularly MMP-9, are significantly elevated and biologically active in the tears of dogs with keratoconjunctivitis.
- These findings highlight the potential role of MMPs as important indicators of corneal deterioration in canine eye diseases.
- Further research into MMPs could lead to improved diagnostic tools and therapeutic strategies for veterinary ophthalmology.